4702-96-9

Upstream product

• 1214-47-7 1-(2-hydroxyphenyl)-3-phenylprop-2-en-1-one 
• 888-12-0 (E)-2'-hydroxy-chalcone 
• 100-52-7 benzaldehyde 
• 118-93-4 o-hydroxyacetophenone 

Downstream Products

• 2726-54-7 3-(2-acetoxy-phenyl)-1-acetyl-5-phenyl-4,5-dihydro-1H-pyrazole 
• 1692-41-7 1-(3-(2-hydroxyphenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)ethanone 
• 19726-12-6 3-(2-hydroxyphenyl)-5-phenyl-pyrazole 
• 1082036-80-3 C₁₇H₁₅ClN₂O₂ 
• 38421-17-9 3-(2-hydroxy-phenyl)-5-phenyl-4,5-dihydro-pyrazole-1-carbothioic acid anilide 
• 1491063-49-0 ethyl 3-(2-hydroxyphenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-1-carboxylate 
• 1491063-57-0 phenyl 3-(2-hydroxyphenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-1-carboxylate 
• 224638-45-3 Mn(C₁₅H₁₃N₂O)2(H₂O)2 
• 224638-72-6 Ni(C₁₅H₁₃N₂O)2(H₂O)2 
• 224638-86-2 Cu(C₁₅H₁₃N₂O)2(H₂O)2 
• 224638-58-8 Co(C₁₅H₁₃N₂O)2(H₂O)2 
• 224639-07-0 Zn(C₁₅H₁₃N₂O)2(H₂O)2 
• 81136-37-0 Acetic acid 2-[5-phenyl-1-(toluene-4-sulfonyl)-4,5-dihydro-1H-pyrazol-3-yl]-phenyl ester 
• 81136-36-9 3-(2-hydroxyphenyl)-5-phenyl-4,5-dihydro-1-toluenesulphonylpyrazole 

Relevant academic research and scientific papers

Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition

In this study, we have designed and synthesized pyrazoline analogues that partially mimic the structure of mycobactin, to address the requirement of novel therapeutics to tackle the emerging global challenge of antimicrobial resistance (AMR). Our investigation resulted in the identification of novel lead compounds 44 and 49 as potential mycobactin biosynthesis inhibitors against mycobacteria. Moreover, candidates efficiently eradicated intracellularly surviving mycobacteria. Thermofluorimetric analysis and molecular dynamics simulations suggested that compounds 44 and 49 bind to salicyl-AMP ligase (MbtA), a key enzyme in the mycobactin biosynthetic pathway. To the best of our knowledge, these are the first rationally designed mycobactin inhibitors to demonstrate an excellent in vivo pharmacokinetic profile. In addition, these compounds also exhibited more potent whole-cell efflux pump inhibition than known efflux pump inhibitors verapamil and chlorpromazine. Results from this study pave the way for the development of 3-(2-hydroxyphenyl)-5-(aryl)-pyrazolines as a new weapon against superbug-associated AMR challenges.

Synthesis, spectral and sol-gel behavior of mixed ligand complexes of titanium(iv) with oxygen, nitrogen and sulfur donor ligands

A new route to synthesize nano-sized Ti(IV) mixed ligand complexes have been investigated by the reaction of titanium(IV) chloride with ammonium salts of dithiophosphate and 3(2'-hydroxyphenyl)-5-(4- substituted phenyl) pyrazolines. The resultant complex is then treated with H2S gas to get sulfur bridged dimer of Ti(IV) complex, a precursor of TiS2. The morphology of the complexes was studied by employing XRD which shows that all the complexes are amorphous solid. Molecular weight measurements, elemental analysis in conjugation with spectroscopic (IR, 1H NMR, 13C NMR and 31P NMR) studies revealed the dimeric nature of the complexes in which pyrazoline and dithiophosphate are bidentate. Scanning electron microscopic image and XRD indicate that the particles are in the nano range (50 nm). Putting all the facts together, coordination number six is proposed for titanium with octahedral geometry.

Preparation method for cadmium, aluminium and lead ion chelating agent

The invention discloses a preparation method for a metal ion chelating agent, belongs to the field of analytical chemistry and environment, and particularly relates to the preparation method for the metal ion chelating agent and application thereof in tre

Copper (II) chloride: A regioselective catalyst for oxidative aromatization of pyrazoline, isoxazoline and 3-methyl flavanones

A new protocol has been reported in which a series of pyrazoline, isoxazoline and 3-methyl flavanone has been conveniently aromatized by using CuCl2.2H2O in DMSO within a short reaction time in excellent yields. The attraction of this new protocol is regioselective aromatization of substrate 3i-j and 5a-e which has been carried out to afford the aromatized product with O-allyl group intact in excellent yield.

Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H- pyrazole-1-carboxylate derivatives

Ethyl and phenyl carbamate derivatives of pyrazoline (3a-3h) were synthesized and tested for their MAO inhibitory activity. All the compounds were found to be selective towards MAO-A. Phenyl carbamates (3e-3h) were better than ethyl carbamates (3a-3d) and

Pyrazoline-based mycobactin analogues as MAO-inhibitors

3,5-Diaryl carbothioamide pyrazolines designed as mycobactin analogs (mycobacterial siderophore) were reported to be potent antitubercular agents under iron limiting condition in our earlier study. Clinical complications of newly introduced antibiotic Linezolid, due its MAO inhibitory activity, prompted us to evaluate our compounds for their MAO-inhibitory activity against rat liver MAO-A and MAO-B as pyrazolines were reported to be antidepressants and MAO inhibitors. The present study carried out with this pilot library of 32 compounds will provide us with necessary information for designing antitubercular molecules with reduced MAO-inhibitory activity and also help us in identifying a selective MAO-B inhibitor which has potential clinical utility in neurodegenerative disorders. Thirty-two compounds analyzed has shown spectrum of activity from selective to nonselective against two isoforms of rat liver MAO-A and MAO-B and also as competitive, reversible to non-competitive, irreversible. It is also interesting to note that anti-tubercular compound 11, 14 and 16 were also found to be selective inhibitors of rat liver MAO-B. Docking studies with human MAO shows that compound 11 interacts with the catalytic site of both the isoforms, suggesting compound 11 as nonselective inhibitor of human MAO isoforms.

Small molecules with structural similarities to siderophores as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis

Drugs inhibiting the iron scarcity-induced, siderophore-mediated iron-scavenging systems of Mycobacterium tuberculosis (Mtb) and Yersinia pestis (Yp) may provide new therapeutic lines of defense. Compounds with structural similarities to siderophores were synthesized and evaluated as antimicrobials against Mtb and Yp under iron-limiting conditions, which mimic the iron scarcity these pathogens encounter and must adapt to in the host, and under standard iron-rich conditions for comparison. New antimicrobials were identified, some of which warrant exploration as initial leads against potentially novel targets and small-molecule tools to assist in the elucidation of targets specific to iron-scarcity adapted Mtb and Yp.

Microwave induced synthesis and anti microbial activities of some [3-(2-hydroxyphenyl)-5-aryl-2-pyrazolinyl]-4-thiazolidenones

A series of new [3-(2-hydroxyphenyl)-5-aryl-2-pyrazolinyi]-4- thiazolidenones (4a-g.) has been prepared by microwave irradiation technique. O-hydroxy chalcones (1) were treated with hydrazine hydrate to afford corresponding pyrazolines (2) which were trea

Synthesis of pyrazoline and isoxazoline in triethanolamine medium

Reactions of chalcones 1a-u with phenylhydrazine and hydrazine hydrate give pyrazolines 2a-u and with hydroxylamine hydrochloride yield isoxazolines 3a-c in triethanolamine medium. The structures of products are established by melting points, chemical studies and spectral data (IR and 1HNMR).

Oxidation of Pyrazolines with Manganese Dioxide

Pyrazolines have been oxidised with manganese dioxide in chloroform at room temperature to give pyrazoles in good yields.